BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 20368579)

  • 21. Caffeine enhances osteoclast differentiation and maturation through p38 MAP kinase/Mitf and DC-STAMP/CtsK and TRAP pathway.
    Choi J; Choi SY; Lee SY; Lee JY; Kim HS; Lee SY; Lee NK
    Cell Signal; 2013 May; 25(5):1222-7. PubMed ID: 23434822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Suppressive effects for osteoclastogenesis regulated by RANKL signal].
    Miyauchi Y; Miyamoto T
    Clin Calcium; 2011 Aug; 21(8):1141-7. PubMed ID: 21814018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aconitum pseudo-laeve var. erectum inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclastogenesis via the c-Fos/nuclear factor of activated T-cells, cytoplasmic 1 signaling pathway and prevents lipopolysaccharide-induced bone loss in mice.
    Baek JM; Kim JY; Cheon YH; Park SH; Ahn SJ; Yoon KH; Oh J; Lee MS
    Molecules; 2014 Aug; 19(8):11628-44. PubMed ID: 25100255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo.
    Franco GC; Kajiya M; Nakanishi T; Ohta K; Rosalen PL; Groppo FC; Ernst CW; Boyesen JL; Bartlett JD; Stashenko P; Taubman MA; Kawai T
    Exp Cell Res; 2011 Jun; 317(10):1454-64. PubMed ID: 21420951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The large zinc finger protein ZAS3 is a critical modulator of osteoclastogenesis.
    Liu S; Madiai F; Hackshaw KV; Allen CE; Carl J; Huschart E; Karanfilov C; Litsky A; Hickey CJ; Marcucci G; Huja S; Agarwal S; Yu J; Caligiuri MA; Wu LC
    PLoS One; 2011 Mar; 6(3):e17161. PubMed ID: 21390242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
    Yang J; Park OJ; Lee YJ; Jung HM; Woo KM; Choi Y
    Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass.
    Mun SH; Won HY; Hernandez P; Aguila HL; Lee SK
    J Bone Miner Res; 2013 Apr; 28(4):948-59. PubMed ID: 23044992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
    Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
    J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transglutaminase 2 regulates osteoclast differentiation via a Blimp1-dependent pathway.
    Kim WS; Kim H; Jeong EM; Kim HJ; Lee ZH; Kim IG; Kim HH
    Sci Rep; 2017 Sep; 7(1):10626. PubMed ID: 28878266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term mechanical stress inhibits osteoclastogenesis via suppression of DC-STAMP in RAW264.7 cells.
    Kameyama S; Yoshimura Y; Kameyama T; Kikuiri T; Matsuno M; Deyama Y; Suzuki K; Iida J
    Int J Mol Med; 2013 Feb; 31(2):292-8. PubMed ID: 23292096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (-)-Epigallocatechin-3-gallate inhibits RANKL-induced osteoclastogenesis via downregulation of NFATc1 and suppression of HO-1-HMGB1-RAGE pathway.
    Nishioku T; Kubo T; Kamada T; Okamoto K; Tsukuba T; Uto T; Shoyama Y
    Biomed Res; 2020; 41(6):269-277. PubMed ID: 33268671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conditional inactivation of Blimp1 in adult mice promotes increased bone mass.
    Miyauchi Y; Miyamoto H; Yoshida S; Mori T; Kanagawa H; Katsuyama E; Fujie A; Hao W; Hoshi H; Miyamoto K; Sato Y; Kobayashi T; Akiyama H; Morioka H; Matsumoto M; Toyama Y; Miyamoto T
    J Biol Chem; 2012 Aug; 287(34):28508-17. PubMed ID: 22761448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
    Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
    J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.
    Okayasu M; Nakayachi M; Hayashida C; Ito J; Kaneda T; Masuhara M; Suda N; Sato T; Hakeda Y
    J Biol Chem; 2012 Jun; 287(23):19229-41. PubMed ID: 22500026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.
    Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N
    J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The L-type amino acid transporter LAT1 inhibits osteoclastogenesis and maintains bone homeostasis through the mTORC1 pathway.
    Ozaki K; Yamada T; Horie T; Ishizaki A; Hiraiwa M; Iezaki T; Park G; Fukasawa K; Kamada H; Tokumura K; Motono M; Kaneda K; Ogawa K; Ochi H; Sato S; Kobayashi Y; Shi YB; Taylor PM; Hinoi E
    Sci Signal; 2019 Jul; 12(589):. PubMed ID: 31289211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oleanolic acid exerts inhibitory effects on the late stage of osteoclastogenesis and prevents bone loss in osteoprotegerin knockout mice.
    Zhao D; Shu B; Wang C; Zhao Y; Cheng W; Sha N; Li C; Wang Q; Lu S; Wang Y
    J Cell Biochem; 2020 Jan; 121(1):152-164. PubMed ID: 31318102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
    Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
    Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bach1 regulates osteoclastogenesis in a mouse model via both heme oxygenase 1-dependent and heme oxygenase 1-independent pathways.
    Hama M; Kirino Y; Takeno M; Takase K; Miyazaki T; Yoshimi R; Ueda A; Itoh-Nakadai A; Muto A; Igarashi K; Ishigatsubo Y
    Arthritis Rheum; 2012 May; 64(5):1518-28. PubMed ID: 22127667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.